Dr. Fox has been on the faculty of the University of Michigan since 1985, and was Chief of the Division of Rheumatology from 1990-2018. His research focuses on defining and characterizing pathways of human T cell activation, determining the role of these pathways in the pathogenesis of autoimmune disease, investigating T cell interactions with synovial fibroblasts, understanding pathways of inflammation in arthritic joints, and understanding the role of interleukin-17 in arthritis. Dr. Fox created the anti-CD6 monoclonal antibody that is a critical component of ATX101. He is author of more than 270 scientific papers and book chapters and has served on the Editorial Boards of Arthritis & Rheumatism and as an Associate Editor of the Journal of Immunology, the Journal of Clinical Investigation, and JCI Insight. He is a member of the American Society for Clinical Investigation and the Association of American Physicians. In 2007-2008, Dr. Fox served as the seventy-first President of the American College of Rheumatology. Dr. Fox also serves as the Director of the University of Michigan’s Clinical Autoimmunity Center of Excellence, and as a Deputy Director of the Immune Tolerance Network, both funded by the NIH.
